Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome

Leukemia Research

Volumn 34, Issue 3, 2010, Pages 328-334

  Hussein, Kais ^a   Theophile, Katharina ^a   Büsche, Guntram ^a   Schlegelberger, Brigitte ^a   Göhring, Gudrun ^a   Kreipe, Hans ^a   Bock, Oliver ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

MDS; MicroRNA; MiR 150; MiR 155; MiR 221; MiR 222; MYB; Myelodysplastic syndrome

Indexed keywords

MICRORNA; MICRORNA 150; MICRORNA 155; MICRORNA 221; MICRORNA 222; PROTEIN MYB; PROTEIN P27; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE TARGETING; HEMATOPOIESIS; HUMAN; HUMAN TISSUE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN RNA BINDING; TRISOMY; X CHROMOSOME;

AGED; CHROMOSOME ABERRATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; MALE; MICRORNAS; MICROSATELLITE REPEATS; MYELODYSPLASTIC SYNDROMES; ONCOGENE PROTEINS V-MYB; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 77649185483     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.06.014     Document Type: Article

References (34)

1. Lawrie C.H. MicroRNAs and haematology: small molecules, big function. Br J Haematol 2007, 137:503-512.
2. Hobert O. Gene regulation by transcription factors and microRNAs. Science 2008, 319:1785-1786.
3. Felli N., Fontana L., Pelosi E., Botta R., Bonci D., Facchiano F., et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005, 102:18081-18086.
4. Choong M.L., Yang H.H., McNiece I. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol 2007, 35:551-564.
5. Bruchova H., Yoon D., Agarwal A.M., Mendell J., Prchal J.T. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 2007, 35:1657-1667.
6. Bruchova H., Merkerova M., Prchal J.T. Aberrant expression of microRNA in polycythemia vera. Haematologica 2008, 93:1009-1016.
7. Guglielmelli P., Tozzi L., Pancrazzi A., Bogani C., Antonioli E., Ponziani V., et al. MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Exp Hematol 2007, 35:1708-1718.
8. O'Connell R.M., Rao D.S., Chaudhuri A.A., Boldin M.P., Taganov K.D., Nicoll J., et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008, 205:585-594.
9. Visone R., Russo L., Pallante P., De Martino I., Ferraro A., Leone V., et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 2007, 14:791-798.
10. Gillies J.K., Lorimer I.A. Regulation of p27Kip1 by miR-221/222 in glioblastoma. Cell Cycle 2007, 6:2005-2009.
11. Felicetti F., Errico M.C., Bottero L., Segnalini P., Stoppacciaro A., Biffoni M., et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008, 68:2745-2754.
12. le Sage C., Nagel R., Egan D.A., Schrier M., Mesman E., Mangiola A., et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 2007, 26:3699-3708.
13. Barroga C.F., Pham H., Kaushansky K. Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression. Exp Hematol 2008, 36:1585-1592.
14. Lu J., Guo S., Ebert B.L., Zhang H., Peng X., Bosco J., et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008, 14:843-853.
15. Wang M., Tan L.P., Dijkstra M.K., van Lom K., Robertus J.L., Harms G., et al. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 2008, 215:13-20.
16. Lei W., Liu F., Ness S.A. Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1. Blood 2005, 105:3855-3861.
17. Vegiopoulos A., García P., Emambokus N., Frampton J. Coordination of erythropoiesis by the transcription factor c-Myb. Blood 2006, 107:4703-4710.
18. Hussein K., Dralle W., Theophile K., Kreipe H., Bock O. Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm. Ann Hematol 2009, 88:325-332.
19. Venturini L., Battmer K., Castoldi M., Schultheis B., Hochhaus A., Muckenthaler M.U., et al. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 2007, 109:4399-4405.
20. Nolte F., Hofmann W.K. Myelodysplastic syndromes: molecular pathogenesis and genomic changes. Ann Hematol 2008, 87:777-795.
21. Li J., Smyth P., Flavin R., Cahill S., Denning K., Aherne S., et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 2007, 7:36.
22. Bock O., Schlué J., Lehmann U., von Wasielewski R., Länger F., Kreipe H. Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression. Blood 2002, 100:2274-2275.
23. -ΔΔCT method. Methods 2001, 25:402-408.
24. Schlegelberger B., Metzke S., Harder S., Zulke-Jenisch R., Zhang Y., Siebert R. Classical and molecular cytogenetics of tumor cells. Cytogenetics 1999, 151-185. Springer-Verlag, New York. R. Wegener (Ed.).
25. Lehmann U., Brakensiek K., Kreipe H. Role of epigenetic changes in hematological malignancies. Ann Hematol 2004, 83:137-152.
26. Bousquet M., Quelen C., Rosati R., Mansat-De Mas V., La Starza R., Bastard C., et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008, 205:2499-2506.
27. Boultwood J., Pellagatti A., Cattan H., Lawrie C.H., Giagounidis A., Malcovati L., et al. Gene expression profiling of CD34+ cells in patients with the 5q-syndrome. Br J Haematol 2007, 139:578-589.
28. Ebert B.L., Pretz J., Bosco J., Chang C.Y., Tamayo P., Galili N., et al. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 2008, 451:335-339.
29. Joslin J.M., Fernald A.A., Tennant T.R., Davis E.M., Kogan S.C., Anastasi J., et al. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood 2007, 110:719-726.
30. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529.
31. Takada S., Yamashita Y., Berezikov E., Hatanaka H., Fujiwara S.I., Kurashina K., et al. MicroRNA expression profiles of human leukemias. Leukemia 2008, 22:1274-1278.
32. Dixon-McIver A., East P., Mein C.A., Cazier J.B., Molloy G., Chaplin T., et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 2008, 3:e2141.
33. Brakensiek K., Länger F., Kreipe H., Lehmann U. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML. Leuk Res 2005, 29:1357-1360.
34. Siitonen T., Savolainen E.R., Koistinen P. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes. Leukemia 1994, 8:631-637.